T1	PROC 1 15	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	CHEM 27 35	propofol
#2	AnnotatorNotes T2	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T3	CHEM 43 51	propofol
#3	AnnotatorNotes T3	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T4	CHEM 56 65	midazolam
#4	AnnotatorNotes T4	C0026056; midazolam; Organic Chemical · Pharmacologic Substance
T5	PROC 69 91	endoscopia diagnóstica
#5	AnnotatorNotes T5	C0014245; Endoscopy (procedure); Diagnostic Procedure + C0011900; Diagnosis; Diagnostic Procedure
T6	PROC 1104 1137	se trataron de forma conservadora
#6	AnnotatorNotes T6	C0459914; Conservative Treatment; Therapeutic or Preventive Procedure
T7	CHEM 159 167	propofol
#7	AnnotatorNotes T7	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T8	CHEM 170 179	midazolam
#8	AnnotatorNotes T8	C0026056; midazolam; Organic Chemical · Pharmacologic Substance
T9	CHEM 195 203	fármacos
#9	AnnotatorNotes T9	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T10	PROC 252 255	EDA
#10	AnnotatorNotes T10	C0079304; Esophagogastroduodenoscopy; Diagnostic Procedure
T11	PROC 225 250	endoscopia digestiva alta
#11	AnnotatorNotes T11	C0079304; Esophagogastroduodenoscopy; Diagnostic Procedure
T12	PROC 298 320	protocolos de sedación
T13	CHEM 338 346	fármacos
#12	AnnotatorNotes T13	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T14	PROC 432 443	exploración
#13	AnnotatorNotes T14	C1280903; Exploration procedure; Therapeutic or Preventive Procedure
T15	PROC 494 542	estudio prospectivo, randomizado y a doble ciego
#14	AnnotatorNotes T15	C0013072; Double-Blind Method; Research Activity + C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T16	PROC 644 659	EDA diagnóstica
#15	AnnotatorNotes T16	C0079304; Esophagogastroduodenoscopy; Diagnostic Procedure + C0011900; Diagnosis; Diagnostic Procedure
T17	CHEM 685 693	propofol
#16	AnnotatorNotes T17	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T18	PROC 698 705	placebo
#17	AnnotatorNotes T18	C0032042; Placebos; Therapeutic or Preventive Procedure
T19	CHEM 718 727	midazolam
#18	AnnotatorNotes T19	C0026056; midazolam; Organic Chemical · Pharmacologic Substance
T20	CHEM 732 740	propofol
#19	AnnotatorNotes T20	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T21	CHEM 825 837	suero salino
#20	AnnotatorNotes T21	C0445115; Normal saline; Inorganic Chemical · Pharmacologic Substance
T22	CHEM 841 849	propofol
#21	AnnotatorNotes T22	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T23	CHEM 942 951	midazolam
#22	AnnotatorNotes T23	C0026056; midazolam; Organic Chemical · Pharmacologic Substance
T24	CHEM 972 980	propofol
#23	AnnotatorNotes T24	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T25	DISO 1046 1062	efectos adversos
#24	AnnotatorNotes T25	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T26	CHEM 1168 1177	midazolam
#25	AnnotatorNotes T26	C0026056; midazolam; Organic Chemical · Pharmacologic Substance
T27	CHEM 1182 1190	propofol
#26	AnnotatorNotes T27	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T28	PROC 1277 1288	exploración
#27	AnnotatorNotes T28	C1280903; Exploration procedure; Therapeutic or Preventive Procedure
T29	PROC 1307 1329	evaluación endoscópica
#28	AnnotatorNotes T29	C0014245; Endoscopy (procedure); Diagnostic Procedure + C0011900; Diagnosis; Diagnostic Procedure
T30	PROC 1462 1470	sedación
#29	AnnotatorNotes T30	C0344106; Sedation procedure; Therapeutic or Preventive Procedure
T31	CHEM 1489 1497	propofol
#30	AnnotatorNotes T31	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T32	PROC 1531 1542	exploración
#31	AnnotatorNotes T32	C1280903; Exploration procedure; Therapeutic or Preventive Procedure
T33	CHEM 1567 1575	propofol
#32	AnnotatorNotes T33	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T34	CHEM 1618 1626	propofol
#33	AnnotatorNotes T34	C0033487; propofol; Organic Chemical · Pharmacologic Substance
T35	PROC 1630 1641	monoterapia
#34	AnnotatorNotes T35	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T36	PROC 1672 1683	exploración
#35	AnnotatorNotes T36	C1280903; Exploration procedure; Therapeutic or Preventive Procedure
T37	PROC 376 379	EDA
#36	AnnotatorNotes T37	C0079304; Esophagogastroduodenoscopy; Diagnostic Procedure
T38	PROC 661 674	aleatorizados
#37	AnnotatorNotes T38	C0034656; Randomization; Research Activity
T39	PROC 816 823	placebo
#38	AnnotatorNotes T39	C0032042; Placebos; Therapeutic or Preventive Procedure
T40	PROC 1226 1234	sedación
#39	AnnotatorNotes T40	C0344106; Sedation procedure; Therapeutic or Preventive Procedure
T41	PROC 1420 1441	regímenes de sedación
#40	AnnotatorNotes T41	C0344106; Sedation procedure; Therapeutic or Preventive Procedure
T42	CHEM 1475 1484	midazolam
#41	AnnotatorNotes T42	C0026056; midazolam; Organic Chemical · Pharmacologic Substance
T43	PROC 1599 1613	administración
#42	AnnotatorNotes T43	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T44	LIVB 95 104	pacientes
#43	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T46	LIVB 350 359	pacientes
#44	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	LIVB 461 469	paciente
#45	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 472 481	Pacientes
#46	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	LIVB 570 579	pacientes
#47	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Age 583 593	18-80 años
T52	LIVB 784 793	pacientes
#48	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Dose 862 867	20 mg
T54	Dose 887 893	115 mg
T55	LIVB 913 922	pacientes
#49	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Dose 934 938	3 mg
T57	Dose 963 968	20 mg
T58	Dose 997 1002	83 mg
T60	LIVB 1143 1152	pacientes
#50	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T62	LIVB 1364 1373	pacientes
#51	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T64	LIVB 1713 1722	pacientes
#52	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T45	Route 808 812	bolo
#53	AnnotatorNotes T45	C1554882; Injection, intravenous, bolus; Functional Concept | C1522229; Intravenous Bolus; Functional Concept
T65	Route 853 858	bolos
#54	AnnotatorNotes T65	C1554882; Injection, intravenous, bolus; Functional Concept | C1522229; Intravenous Bolus; Functional Concept
T66	Route 954 959	bolos
#55	AnnotatorNotes T66	C1554882; Injection, intravenous, bolus; Functional Concept | C1522229; Intravenous Bolus; Functional Concept
T59	PROC 622 625	ASA
#56	AnnotatorNotes T59	C4751522; Assessment using American Society of Anesthesiologists Physical Status Classification System; Health Care Activity
T61	Neg_cue 1004 1006	No
T63	CONC 1012 1023	diferencias
A1	Assertion T63 Negated
#57	AnnotatorNotes T63	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T61 Arg2:T63	
T67	Neg_cue 1498 1500	no
T68	CONC 1501 1507	afecta
A2	Assertion T68 Negated
R2	Negation Arg1:T67 Arg2:T68	
T69	CONC 1247 1253	variar
A3	Assertion T69 Negated
#58	AnnotatorNotes T69	C0205419; Variant; Qualitative Concept (?)
T70	Neg_cue 1243 1246	sin
R3	Negation Arg1:T70 Arg2:T69	
R4	Combined_with Arg1:T3 Arg2:T4	
T71	Observation 113 130	riesgo anestésico
#59	AnnotatorNotes T71	C4544425; At risk of complication of anesthesia; Finding
T72	Quantifier_or_Qualifier 108 112	bajo
#60	AnnotatorNotes T72	C0205251; low; Qualitative Concept
R5	Has_Quantifier_or_Qualifier Arg1:T71 Arg2:T72	
R6	Experiences Arg1:T44 Arg2:T71	
T73	Quantifier_or_Qualifier 598 602	bajo
#61	AnnotatorNotes T73	C0205251; low; Qualitative Concept
T74	Observation 603 620	riesgo anestésico
#62	AnnotatorNotes T74	C4544425; At risk of complication of anesthesia; Finding
R7	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T73	
T75	Result_or_Value 626 630	I-II
R8	Has_Result_or_Value Arg1:T59 Arg2:T75	
R9	Has_Age Arg1:T49 Arg2:T50	
R10	Experiences Arg1:T49 Arg2:T74	
R11	Combined_with Arg1:T7 Arg2:T8	
R12	Experiences Arg1:T46 Arg2:T13	
R13	Experiences Arg1:T46 Arg2:T37	
R14	Experiences Arg1:T47 Arg2:T37	
R15	Experiences Arg1:T46 Arg2:T14	
R16	Experiences Arg1:T47 Arg2:T14	
R17	Experiences Arg1:T47 Arg2:T13	
R18	Experiences Arg1:T49 Arg2:T16	
R19	Experiences Arg1:T49 Arg2:T17	
R20	Combined_with Arg1:T17 Arg2:T18	
R21	Experiences Arg1:T49 Arg2:T19	
R22	Combined_with Arg1:T19 Arg2:T20	
R23	Before Arg1:T38 Arg2:T17	
R24	Before Arg1:T38 Arg2:T19	
R25	Experiences Arg1:T52 Arg2:T39	
R26	Used_for Arg1:T21 Arg2:T39	
R27	Combined_with Arg1:T39 Arg2:T22	
R28	Combined_with Arg1:T21 Arg2:T22	
R29	Has_Route_or_Mode Arg1:T22 Arg2:T65	
R30	Has_Dose_or_Strength Arg1:T22 Arg2:T53	
R32	Has_Route_or_Mode Arg1:T21 Arg2:T45	
R33	Has_Dose_or_Strength Arg1:T22 Arg2:T54	
R34	Experiences Arg1:T55 Arg2:T23	
R35	Has_Dose_or_Strength Arg1:T23 Arg2:T56	
R36	Has_Route_or_Mode Arg1:T24 Arg2:T66	
R37	Combined_with Arg1:T23 Arg2:T24	
R38	Has_Dose_or_Strength Arg1:T24 Arg2:T57	
R39	Has_Dose_or_Strength Arg1:T24 Arg2:T58	
R41	Experiences Arg1:T60 Arg2:T26	
R42	Combined_with Arg1:T26 Arg2:T27	
R43	Before Arg1:T2 Arg2:T5	
R44	Before Arg1:T3 Arg2:T5	
R45	Experiences Arg1:T44 Arg2:T5	
R46	Experiences Arg1:T44 Arg2:T3	
R47	Experiences Arg1:T44 Arg2:T2	
R48	Before Arg1:T9 Arg2:T11	
R49	Before Arg1:T9 Arg2:T10	
R50	Before Arg1:T7 Arg2:T11	
R51	Before Arg1:T7 Arg2:T10	
R52	Before Arg1:T13 Arg2:T37	
R53	Before Arg1:T13 Arg2:T14	
R54	Experiences Arg1:T49 Arg2:T59	
R55	Before Arg1:T17 Arg2:T16	
R56	Before Arg1:T19 Arg2:T16	
R57	Before Arg1:T59 Arg2:T16	
R58	Used_for Arg1:T26 Arg2:T40	
R59	Before Arg1:T40 Arg2:T28	
R60	Experiences Arg1:T60 Arg2:T40	
R61	Experiences Arg1:T60 Arg2:T28	
R62	Experiences Arg1:T62 Arg2:T29	
R63	Experiences Arg1:T62 Arg2:T41	
R64	Before Arg1:T41 Arg2:T29	
T76	Observation 1398 1409	satisfechos
#63	AnnotatorNotes T76	C3476649; Treatment satisfaction; Finding
R65	Experiences Arg1:T62 Arg2:T76	
R66	Before Arg1:T29 Arg2:T76	
R67	Used_for Arg1:T42 Arg2:T30	
R68	Combined_with Arg1:T42 Arg2:T31	
R69	Before Arg1:T30 Arg2:T32	
R70	Used_for Arg1:T33 Arg2:T30	
R71	Used_for Arg1:T34 Arg2:T35	
R72	Used_for Arg1:T34 Arg2:T43	
R73	Before Arg1:T43 Arg2:T30	
R74	Before Arg1:T35 Arg2:T30	
R75	Before Arg1:T43 Arg2:T36	
R76	Before Arg1:T35 Arg2:T36	
R77	Experiences Arg1:T64 Arg2:T36	
R78	Experiences Arg1:T64 Arg2:T35	
R79	Experiences Arg1:T64 Arg2:T43	
R80	Experiences Arg1:T64 Arg2:T33	
R81	Experiences Arg1:T64 Arg2:T32	
R82	Experiences Arg1:T64 Arg2:T30	
T77	Quantifier_or_Qualifier 1024 1038	significativas
A4	Assertion T77 Negated
#64	AnnotatorNotes T77	C0750502; Significant; Idea or Concept
R83	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T77	
R84	Negation Arg1:T61 Arg2:T77	
#65	AnnotatorNotes T68	C4054723; Influence; Conceptual Entity (?) 
R40	Overlap Arg1:T76 Arg2:T41	
A5	Experiencer T44 Patient
A6	Experiencer T46 Patient
A7	Experiencer T47 Patient
A8	Experiencer T48 Patient
A9	Experiencer T52 Patient
A10	Experiencer T55 Patient
A11	Experiencer T60 Patient
A12	Experiencer T62 Patient
A13	Experiencer T64 Patient
A14	Experiencer T49 Patient
